• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Total number of Public Inquiries by month (includes phone, email, and letter inquiries)

Dictionary: The Division of Drug Information within CDER is responsible for answering the public's questions about the regulatory mission of FDA. Questions arrive in the form of emails or postal mail. The public also calls the agency with many questions. This measure tracks the number of public inquiries CDER receives each month. It is CDER's goal to always respond to all public inquiries.


These measures have been retired as CDER has created new measures for FY13 which align to their four functional areas of 1) Regulatory Review and Drug Safety, 2) Drug Quality and Compliance, 3) Transparency and Public Outreach, and 4) Regulatory Science Research.

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetNumber
Oct 2011N/A6,534
Nov 2011N/A5,281
Dec 2011N/A5,590
Jan 2012N/ATBD
Feb 2012N/ATBD
Mar 2012N/ATBD
Apr 2012N/ATBD
May 2012N/ATBD
Jun 2012N/ATBD
Jul 2012N/ATBD
Aug 2012N/ATBD
Sep 2012N/ATBD

FY 2012 YTD: 17,405

Number of phone inquires received in the month

Dictionary: The Division of Drug Information within CDER is responsible for answering the public's questions about the regulatory mission of FDA. Questions arrive in the form of emails or postal mail. The public also calls the agency with many questions. This measure tracks the number of public inquiries CDER receives each month. It is CDER's goal to always respond to all public inquiries.

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetNumber
Oct 2011N/A4,953
Nov 2011N/A3,993
Dec 2011N/A4,351
Jan 2012N/ATBD
Feb 2012N/ATBD
Mar 2012N/ATBD
Apr 2012N/ATBD
May 2012N/ATBD
Jun 2012N/ATBD
Jul 2012N/ATBD
Aug 2012N/ATBD
Sep 2012N/ATBD

FY 2012 YTD: 13,297

Percent of phone calls with first contact resolution (i.e., phone call answered by FDA staff and response given; this statistic does not include phone calls received during non-business hours)

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetPercent
Oct 2011N/A75
Nov 2011N/A76
Dec 2011N/A77
Jan 2012N/ATBD
Feb 2012N/ATBD
Mar 2012N/ATBD
Apr 2012N/ATBD
May 2012N/ATBD
Jun 2012N/ATBD
Jul 2012N/ATBD
Aug 2012N/ATBD
Sep 2012N/ATBD

FY 2012 3-month average: 76%

Number of email inquires received in the month

Dictionary: The Division of Drug Information within CDER is responsible for answering the public's questions about the regulatory mission of FDA. Questions arrive in the form of emails or postal mail. The public also calls the agency with many questions. This measure tracks the number of public inquiries CDER receives each month. It is CDER's goal to always respond to all public inquiries.

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetNumber
Oct 2011N/A1,471
Nov 2011N/A1,269
Dec 2011N/A1,146
Jan 2012N/ATBD
Feb 2012N/ATBD
Mar 2012N/ATBD
Apr 2012N/ATBD
May 2012N/ATBD
Jun 2012N/ATBD
Jul 2012N/ATBD
Aug 2012N/ATBD
Sep 2012N/ATBD

FY 2012 YTD: 3,886

Percent of emails responded to in 48 hours in the month

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetPercent
Oct 2011N/A100
Nov 2011N/A100
Dec 2011N/A100
Jan 2012N/ATBD
Feb 2012N/ATBD
Mar 2012N/ATBD
Apr 2012N/ATBD
May 2012N/ATBD
Jun 2012N/ATBD
Jul 2012N/ATBD
Aug 2012N/ATBD
Sep 2012N/ATBD

Number of letter correspondence received by CDER's Office of Communication in the month (30 day due date from time of receipt for a response by CDER's Office of Communications

Dictionary: The Division of Drug Information within CDER is responsible for answering the public's questions about the regulatory mission of FDA. Questions arrive in the form of emails or postal mail. The public also calls the agency with many questions. This measure tracks the number of public inquiries CDER receives each month. It is CDER's goal to always respond to all public inquiries.

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetNumber
Oct 2011N/A110
Nov 2011N/A73
Dec 2011N/A93
Jan 2012N/ATBD
Feb 2012N/ATBD
Mar 2012N/ATBD
Apr 2012N/ATBD
May 2012N/ATBD
Jun 2012N/ATBD
Jul 2012N/ATBD
Aug 2012N/ATBD
Sep 2012N/ATBD

FY 2012 YTD: 276

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.